Oct. 22 at 3:27 PM
$IGC
Innovation in Alzheimer’s research starts with rethinking how we use data.
IGC Pharma’s AI-driven platform, AHA: Agentic Harmonization Assistant, has been recognized on the global stage—advancing to the semi-finals of the Alzheimer’s Insights AI Prize organized by the Alzheimer’s Disease Data Initiative (ADDI).
By building on the foundation of MINT-AD, our deep-learning platform that unites complex clinical and biological information, we’re pushing the boundaries of what’s possible in Alzheimer’s drug discovery.
For more information, please visit: https://bit.ly/47D7n9C
#AlzheimersResearch #AIinHealthcare #HealthcareInnovation #Neuroscience #IGCPharma